Search results
Results from the WOW.Com Content Network
In September 2020, Sinovac began Phase I–II trials in China on children and adolescents ages 3–17. [92] In May 2021, Sinovac began Phase IIb trials in China with 500 participants for children and adolescents 3–17 years old. [93] In June 2021, it was announced that the vaccine was safe and immunogenic in this age group. [94]
The World Health Organization (WHO) said on Tuesday it has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing, paving the way for a second Chinese shot to be used in ...
Offering Sinovac Biotech COVID-19 vaccines to the public in Singapore for the first time since Friday, several private clinics reported overwhelming demand for the Chinese-made shot, despite ...
CoronaVac is an inactivated virus COVID-19 vaccine developed by Sinovac. [7] It has been in Phase III clinical trials in Brazil, [8] Chile, [9] Indonesia, [10] Philippines, [11] and Turkey. [12] It relies on traditional technology similar to the Sinopharm BIBP vaccine and Covaxin, otherwise known as inactivated-virus COVID-19 vaccines in Phase ...
The BIBP vaccine could be transported and stored at normal refrigerated temperatures. [17] The vaccine is being used in vaccination campaigns by certain countries in Asia, [18] [19] [20] Africa, [21] [22] [23] South America, [24] [25] [26] and Europe. [27] [28] [29] Sinopharm expects to produce one billion doses of the vaccine in 2021. [30]
California Gov. Gavin Newsom has announced that the state will extend COVID-19 vaccine eligibility to everyone ages 16 and older on April 15. During a press conference on Thursday, Newsom also ...
However, the vaccine was not authorised for use by the Health Sciences Authority (HSA). [12] [13] On 2 June 2021, MOH approved the Sinovac vaccine for used in private healthcare settings so people, who are not suitable to take the mRNA vaccines, can take the Sinovac vaccine. However, since the China-made vaccine is not part of the national ...
The updated COVID-19 vaccine could be available any day, a promising development for California and the nation amid a potent and enduring summer wave of the disease.